HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Naonobu Sugiyama Selected Research

Rheumatoid Arthritis

7/2023Six-month safety and effectiveness of tofacitinib in patients with rheumatoid arthritis in Japan: Interim analysis of post-marketing surveillance.
1/2023Malignancy risk with tofacitinib versus TNF inhibitors in rheumatoid arthritis: results from the open-label, randomised controlled ORAL Surveillance trial.
1/2020RETRACTED ARTICLE: Safety and effectiveness of high-dose methotrexate (over 8 mg/week) in 2838 Japanese patients with rheumatoid arthritis: A postmarketing surveillance report.
1/2020Safety and effectiveness of high-dose methotrexate (over 8 mg/week) in 2838 Japanese patients with rheumatoid arthritis: a postmarketing surveillance report.
9/2019Three-year safety and two-year effectiveness of etanercept in patients with rheumatoid arthritis in Japan: Results of long-term postmarketing surveillance.
9/2019Efficacy and safety of tofacitinib in Japanese patients with rheumatoid arthritis by background methotrexate dose: A post hoc analysis of clinical trial data.
6/2019Efficacy and safety of tofacitinib for the treatment of rheumatoid arthritis in patients from the Asia-Pacific region: Post-hoc analyses of pooled clinical study data.
1/2019Modified- versus immediate-release tofacitinib in Japanese rheumatoid arthritis patients: a randomized, phase III, non-inferiority study.
6/2016Treatment Patterns, Direct Cost of Biologics, and Direct Medical Costs for Rheumatoid Arthritis Patients: A Real-world Analysis of Nationwide Japanese Claims Data.
1/2016Tofacitinib, an oral Janus kinase inhibitor, as monotherapy or with background methotrexate, in Japanese patients with rheumatoid arthritis: an open-label, long-term extension study.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Naonobu Sugiyama Research Topics

Disease

11Rheumatoid Arthritis
07/2023 - 03/2015
3Neoplasms (Cancer)
07/2023 - 01/2016
3Infections
07/2023 - 01/2016
2Herpes Zoster
07/2023 - 01/2016
2Nephritis
05/2007 - 12/2005
2Glomerulonephritis
05/2007 - 12/2005
1Psoriasis (Pustulosis Palmaris et Plantaris)
12/2023
1Necrosis
01/2023
1Lung Neoplasms (Lung Cancer)
01/2023
1Arthritis (Polyarthritis)
01/2018
1Juvenile Arthritis (Juvenile Idiopathic Arthritis)
01/2018
1Skin Neoplasms (Skin Cancer)
01/2016
1Melanoma (Melanoma, Malignant)
01/2016
1Obesity
08/2013
1Insulin Resistance
08/2013
1Inflammation (Inflammations)
08/2013
1Pulmonary Arterial Hypertension
08/2013
1Connective Tissue Diseases (Connective Tissue Disease)
08/2013
1Lymphadenopathy
12/2005
1Membranous Glomerulonephritis (Membranous Nephropathy)
12/2005
1Lupus Nephritis
12/2005
1Sialadenitis
12/2005

Drug/Important Bio-Agent (IBA)

6tofacitinibIBA
07/2023 - 01/2016
5Methotrexate (Mexate)FDA LinkGeneric
01/2020 - 03/2015
4Etanercept (Enbrel)FDA Link
09/2019 - 03/2015
3Janus Kinase InhibitorsIBA
07/2023 - 01/2016
2Antirheumatic Agents (DMARD)IBA
12/2023 - 03/2015
2Abatacept (Orencia)FDA Link
06/2016 - 08/2013
1GlucocorticoidsIBA
12/2023
1Tumor Necrosis Factor InhibitorsIBA
01/2023
1golimumabFDA Link
06/2016
1Adalimumab (Humira)FDA Link
06/2016
1Infliximab (Remicade)FDA Link
06/2016
1tocilizumab (atlizumab)FDA Link
06/2016
1Insulin (Novolin)FDA Link
08/2013
1ArginaseIBA
08/2013
1beta-cyclodextrin tetradecasulfate (CTDS)IBA
08/2013
1Phosphates (Orthophosphate)IBA
05/2007
1LigandsIBA
05/2007
1Poly I-CIBA
05/2007
1CytokinesIBA
05/2007
1Immunoglobulin E (IgE)IBA
12/2005
1SolutionsIBA
12/2005
1Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA
12/2005
1Imatinib Mesylate (Gleevec)FDA Link
12/2005
1Therapeutic UsesIBA
12/2005
1Interleukin-27 (Interleukin 27)IBA
12/2005
1Platelet-Derived Growth FactorIBA
12/2005
1Immunoglobulin G (IgG)IBA
12/2005

Therapy/Procedure

1Immunotherapy
08/2013
1Therapeutics
08/2013